minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions
: cancer-related-medication-request-gefitinib - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicationRequest ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "cancer-related-medication-request-gefitinib"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: MedicationRequest</b><a name=\"cancer-related-medication-request-gefitinib\"> </a><a name=\"hccancer-related-medication-request-gefitinib\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource MedicationRequest "cancer-related-medication-request-gefitinib" </p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-mcode-cancer-related-medication-request.html\">Cancer-Related Medication Request Profile</a></p></div><p><b>Procedure Intent Extension</b>: Curative - procedure intent <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#373808002)</span></p><p><b>Normalization Basis Extension</b>: Body surface area (observable entity) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#301898006)</span></p><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: gefitinib 250 MG Oral Tablet <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html\">RxNorm</a>#349472)</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-john-anyperson.html\">Patient/cancer-patient-john-anyperson</a> " ANYPERSON"</p><p><b>authoredOn</b>: 2019-04-01</p><p><b>requester</b>: <a href=\"Practitioner-us-core-practitioner-kyle-anydoc.html\">Practitioner/us-core-practitioner-kyle-anydoc</a> " ANYDOC"</p><p><b>reasonCode</b>: Non-small cell lung cancer (disorder) <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#254637007)</span></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: 250mg orally once daily with or without food</p><p><b>timing</b>: Code: QD, Events: 2019-04-01, Starting 2019-04-30, Once per 1 days</p><p><b>route</b>: Oral use <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"https://browser.ihtsdotools.org/\">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote></blockquote></div>"
] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-procedure-intent"^^xsd:anyURI ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
a sct:373808002 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "373808002" ] ;
fhir:display [ fhir:v "Curative - procedure intent" ] ] ) ]
] [
fhir:url [ fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis"^^xsd:anyURI ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
a sct:301898006 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "301898006" ] ;
fhir:display [ fhir:v "Body surface area (observable entity)" ] ] ) ]
] ) ; #
fhir:status [ fhir:v "active"] ; #
fhir:intent [ fhir:v "order"] ; #
fhir:medication [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "349472" ] ;
fhir:display [ fhir:v "gefitinib 250 MG Oral Tablet" ] ] )
] ; #
fhir:subject [
fhir:reference [ fhir:v "Patient/cancer-patient-john-anyperson" ]
] ; #
fhir:authoredOn [ fhir:v "2019-04-01"^^xsd:date] ; #
fhir:requester [
fhir:reference [ fhir:v "Practitioner/us-core-practitioner-kyle-anydoc" ]
] ; #
fhir:reasonCode ( [
( fhir:coding [
a sct:254637007 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "254637007" ] ;
fhir:display [ fhir:v "Non-small cell lung cancer (disorder)" ] ] )
] ) ; #
fhir:dosageInstruction ( [
fhir:text [ fhir:v "250mg orally once daily with or without food" ] ;
fhir:timing [
( fhir:event [ fhir:v "2019-04-01"^^xsd:date ] ) ;
fhir:repeat [
fhir:bounds [
a fhir:Period ;
fhir:start [ fhir:v "2019-04-30"^^xsd:date ] ] ;
fhir:frequency [ fhir:v "1"^^xsd:positiveInteger ] ;
fhir:period [ fhir:v "1"^^xsd:decimal ] ;
fhir:periodUnit [ fhir:v "d" ] ] ;
fhir:code [
( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-GTSAbbreviation"^^xsd:anyURI ] ;
fhir:code [ fhir:v "QD" ] ] ) ] ] ;
fhir:route [
( fhir:coding [
a sct:26643006 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "26643006" ] ;
fhir:display [ fhir:v "Oral use" ] ] ) ] ;
( fhir:doseAndRate [
fhir:dose [
a fhir:Quantity ;
fhir:value [ fhir:v "250"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg" ] ;
fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "mg" ] ] ] )
] ) . #
|
Propose a change